| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
SYN-TECH Chem. & Pharm. Co. Ltd (TWO: 1777)
1777 Technical Analysis
5
| As on 12th Jan 2026 1777 STOCK Price closed @ 72.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 87.20 & Strong Sell for SHORT-TERM with Stoploss of 94.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
1777STOCK Price
| Open | 72.40 | Change | Price | % |
| High | 72.60 | 1 Day | 0.20 | 0.28 |
| Low | 71.60 | 1 Week | -1.20 | -1.63 |
| Close | 72.60 | 1 Month | -4.80 | -6.20 |
| Volume | 79076 | 1 Year | -24.60 | -25.31 |
| 52 Week High 108.00 | 52 Week Low 72.00 | ||||
TWO Taiwan Most Active Stocks
| 5347 | 119.00 | 9.68% |
| 8074 | 56.00 | -0.53% |
| 3105 | 233.00 | 7.62% |
| 1815 | 87.20 | -1.25% |
| 6190 | 49.90 | 3.96% |
| 8042 | 62.90 | -1.41% |
| 6603 | 34.35 | 2.69% |
| 8043 | 86.20 | -1.37% |
| 6182 | 35.85 | 8.47% |
| 6163 | 65.60 | 9.88% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 1777 Daily Charts |
1777 Intraday Charts |
Whats New @ Bazaartrend |
1777 Free Analysis |
|
|
1777 Important Levels Intraday
| RESISTANCE | 74.53 |
| RESISTANCE | 73.91 |
| RESISTANCE | 73.53 |
| RESISTANCE | 73.15 |
| SUPPORT | 72.06 |
| SUPPORT | 71.67 |
| SUPPORT | 71.29 |
| SUPPORT | 70.67 |
1777 Forecast January 2026
| 4th UP Forecast | 80.89 |
| 3rd UP Forecast | 78.23 |
| 2nd UP Forecast | 76.59 |
| 1st UP Forecast | 74.94 |
| 1st DOWN Forecast | 70.26 |
| 2nd DOWN Forecast | 68.61 |
| 3rd DOWN Forecast | 66.97 |
| 4th DOWN Forecast | 64.31 |
1777 Weekly Forecast
| 4th UP Forecast | 81.46 |
| 3rd UP Forecast | 78.62 |
| 2nd UP Forecast | 76.86 |
| 1st UP Forecast | 75.11 |
| 1st DOWN Forecast | 70.09 |
| 2nd DOWN Forecast | 68.34 |
| 3rd DOWN Forecast | 66.58 |
| 4th DOWN Forecast | 63.74 |
1777 Forecast2026
| 4th UP Forecast | 146.6 |
| 3rd UP Forecast | 122.87 |
| 2nd UP Forecast | 108.2 |
| 1st UP Forecast | 93.53 |
| 1st DOWN Forecast | 51.67 |
| 2nd DOWN Forecast | 37 |
| 3rd DOWN Forecast | 22.33 |
| 4th DOWN Forecast | -1.4 |
SYN-TECH Chem. & Pharm. Co. Ltd ( TWO Taiwan Symbol : 1777 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
1777 Business Profile
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells APIs in Taiwan, Japan, Korea, Europe, the United States, and internationally. It offers products various categories, such as anticoagulant, attention deficit hyperactivity disorder, antihyperlipoproteinemic, antipruritic, scabicide, hyperparathyroidism, calcimimetic, anxiolytic, muscle relaxant, skeletal muscle relaxant, antitussive, anti-inflammatory, antipyretic, analgesic, antiemetic, dipeptidyl peptidase 4 inhibitor, anticonvulsant, antiulcerative, antihyertensive, vasodilator, anxiolytic, tranquilizer, bronchodilator, local anesthetic, decongestant, antispasmodic, antimigraine, overactive bladder, hvponatremia, antiglaucoma agent, and antitussive. The company was founded in 1982 and is based in Tainan City, Taiwan. Address: No. 168 Kai Yuan Road, Tainan City, Taiwan, 73055
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service